TESARO Announces Participation at Two Investor Conferences
September 19 2018 - 4:15PM
TESARO, Inc. (NASDAQ: TSRO), an oncology-focused biopharmaceutical
company, today announced its participation in two upcoming investor
conferences. The two conferences are:
- The Cantor Global Healthcare Conference at the
InterContinental New York Barclay Hotel on Wednesday, October 3,
2018. Lonnie Moulder, CEO of TESARO, and Mary Lynne
Hedley, Ph.D., President and COO of TESARO, are scheduled to
present an overview of the Company’s business and development
programs at 11:30 AM ET and will also host meetings with
investors.
- The Leerink Partners Roundtable Series: Rare Disease
& Oncology at the Lotte New York Palace on Wednesday, October
3, 2018. Mary Lynne Hedley, Ph.D., President and COO of
TESARO, and Timothy Pearson, Executive Vice President and CFO of
TESARO, will participate in an analyst-led fireside chat at 1:30 PM
ET and will also host meetings with investors.
Live webcasts of the presentations at the Cantor
and Leerink Partners conferences will be available by visiting the
Investors section of the TESARO website at www.tesarobio.com.
Archived replays of these webcasts will be available on the
Company’s website for 14 days following the conferences.
About TESAROTESARO is an
oncology-focused biopharmaceutical company devoted to providing
transformative therapies to people facing cancer. For more
information, visit www.tesarobio.com, and follow us on Twitter and
LinkedIn.
For additional information, please
contact:Kate Rausch1.781.257.2505krausch@tesarobio.com
Tesaro, Inc. (NASDAQ:TSRO)
Historical Stock Chart
From Mar 2024 to Apr 2024
Tesaro, Inc. (NASDAQ:TSRO)
Historical Stock Chart
From Apr 2023 to Apr 2024